Organigram Global Inc. (OGI) stock
OGINasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.83−0.01 (-0.65%)
Close on Nov 13, 2026Market cap $111.41MP/E –Yield –
Organigram Global EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -0.19 CAD. The highest annual figure on record is 0.65 CAD in fiscal 2018.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -0.19 CAD | – |
| FY2022 | Aug 31, 2022 | -0.18 CAD | – |
| FY2021 | Aug 31, 2021 | -2.04 CAD | – |
| FY2020 | Aug 31, 2020 | -3.16 CAD | – |
| FY2019 | Aug 31, 2019 | -0.27 CAD | -142.0% |
| FY2018 | Aug 31, 2018 | 0.65 CAD | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?